J1413 Injection delandistrogene mox rokl
J-Codes
Also known as: delandistrogene moxeparvovec, SMA gene therapy
Delandistrogene moxeparvovec injection. A gene therapy for spinal muscular atrophy type 1 administered intravenously.
Clinical Context
Used for spinal muscular atrophy type 1 (SMA1), a severe genetic neuromuscular disease in infants. Gene therapy designed to restore SMN protein production. Single-dose therapy with potential for sustained benefit.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.